T
REGN icon

TradeWorx’s Regeneron Pharmaceuticals REGN Stock Holding History

TradeWorx’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,125
Closed -$338K – 437
2014
Q1 		$338K Buy
+1,125
New +$347K 0.29% 145
2013
Q3 		– Sell
-2,646
Closed -$595K – 573
2013
Q2 		$595K Buy
+2,646
New +$616K 0.26% 121

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TradeWorx's REGN Position: Q2 2014 in Review

TradeWorx sold out of Regeneron Pharmaceuticals (REGN) in Q2 2014, closing a stake of 1,125 shares — an estimated $338K sold.

TradeWorx first reported a position in REGN in Q2 2013 and held it in 2 quarters. The position peaked at $595K in Q2 2013. 448 funds tracked by Wall St. Rank hold REGN as of Q2 2014.

  • TradeWorx reported no remaining Regeneron Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • TradeWorx sold 1,125 Regeneron Pharmaceuticals shares in Q2 2014, an estimated $338K.
  • TradeWorx first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 2 quarters.
  • TradeWorx's Regeneron Pharmaceuticals position peaked at $595K in Q2 2013.
  • 448 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2014.

Based on TradeWorx's 13F filing for Q2 2014, filed 10 Jul 2014.